Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells

Journal of Cellular Physiology

Volumn 231, Issue 8, 2016, Pages 1832-1841

  Di Fiore, Riccardo ^a   Drago Ferrante, Rosa ^a   Pentimalli, Francesca ^b   Di Marzo, Domenico ^b   Forte, Iris Maria ^b   Carlisi, Daniela ^a   De Blasio, Anna ^a   Tesoriere, Giovanni ^c   Giordano, Antonio ^c   Vento, Renza ^a,c  

^a UNIVERSITY OF PALERMO   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c Temple University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CHEMOKINE RECEPTOR CXCR4; GELATINASE B; HIGH MOBILITY GROUP A2 PROTEIN; LET 7D MICRORNA; LIN 28 HOMOLOG B; MICRORNA; NERVE CELL ADHESION MOLECULE; OCTAMER TRANSCRIPTION FACTOR 4; ORGANIC CATION TRANSPORTER 3; PROTEIN BCL 2; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN; VERSICAN; VIMENTIN; APOPTOSIS REGULATORY PROTEIN; CELL CYCLE PROTEIN; MIRNLET7 MICRORNA, HUMAN; TRANSCRIPTION FACTOR;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER STEM CELL; CELL CYCLE PHASE; CELL DEATH; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; COLONY FORMING UNIT; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; LINEAR ENERGY TRANSFER; NUCLEOTIDE SEQUENCE; ONCOGENE; OSTEOSARCOMA CELL; PLASMID; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; STABLE TRANSFECTION; WESTERN BLOTTING; WOUND HEALING; BONE NEOPLASMS; CELL CYCLE; CELL MOTION; CELL SELF-RENEWAL; DRUG EFFECTS; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; OSTEOSARCOMA; PATHOLOGY; PHENOTYPE; SIGNAL TRANSDUCTION; TIME FACTOR; TUMOR CELL LINE; TUMOR INVASION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BONE NEOPLASMS; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL SELF RENEWAL; DRUG RESISTANCE, NEOPLASM; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASTIC STEM CELLS; OSTEOSARCOMA; PHENOTYPE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 84955602332     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.25291     Document Type: Article

References (50)

1. Abbas T, Dutta A. 2009. P21 in cancer: Intricate networks and multiple activities. Nat Rev Cancer 9:400-414.
2. Ali S, Saleh H, Sethi S, Sarkar FH, Philip PA. 2012. MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer. Br J Cancer 107:1354-1360.
3. Büssing I, Slack FJ, Grosshans H. 2008. Let-7 microRNAs in development, stem cells and cancer. Trends Mol Med 14:400-409.
4. Barh D, Malhotra R, Ravi B, Sindhurani P. 2010. Microrna let-7: An emerging next-generation cancer therapeutic. Curr Oncol 17:70-80.
5. Bartuma H, Panagopoulos I, Collin A, Trombetta D, Domanski HA, Mandahl N, Mertens F. 2009. Expression levels of HMGA2 in adipocytic tumors correlate with morphologic and cytogenetic subgroups. Mol Cancer 8:36.
6. Boyerinas B, Park SM, Shomron N, Hedegaard MM, Vinther J, Andersen JS, Feig C, Xu J, Burge CB, Peter ME. 2008. Identification of let-7-regulated oncofetal genes. Cancer Res 68:2587-2591.
7. Boyerinas B, Park SM, Hau A, Murmann AE, Peter ME. 2010. The role of let-7 in cell differentiation and cancer. Endocr Relat Cancer 17:F19-F36.
8. Cabrera MC, Hollingsworth RE, Hurt EM. 2015. Cancer stem cell plasticity and tumor hierarchy. World J Stem Cells 7:27-36.
9. Chang CJ, Hsu CC, Chang CH, Tsai LL, Chang YC, Lu SW, Yu CH, Huang HS, Wang JJ, Tsai CH, Chou MY, Yu CC, Hu FW. 2011. Let-7d functions as novel regulator of epithelial-mesenchymal transition and chemoresistant property in oral cancer. Oncol Rep 26:1003-1010.
10. Choi E, Choi E, Hwang KC. 2013. MicroRNAs as novel regulators of stem cell fate. World J Stem Cells 5:172-187.
11. Di Fiore R, Santulli A, Ferrante RD, Giuliano M, De Blasio A, Messina C, Pirozzi G, Tirino V, Tesoriere G, Vento R. 2009. Identification and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment. J Cell Physiol 219:301-313.
12. Di Fiore R, Guercio A, Puleio R, Di Marco P, Drago-Ferrante R, D'Anneo A, De Blasio A, Carlisi D, Di Bella S, Pentimalli F, Forte IM, Giordano A, Tesoriere G, Vento R. 2012. Modeling human osteosarcoma in mice through 3AB-OS cancer stem cell xenografts. J Cell Biochem 113:3380-3392.
13. Di Fiore R, Fanale D, Drago-Ferrante R, Chiaradonna F, Giuliano M, De Blasio A, Amodeo V, Corsini LR, Bazan V, Tesoriere G, Vento R, Russo A. 2013. Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: A possible model for studying osteosarcoma origin and stemness. J Cell Physiol 228:1189-1201.
14. Di Fiore R, Drago-Ferrante R, Pentimalli F, Di Marzo D, Forte IM, D'Anneo A, Carlisi D, De Blasio A, Giuliano M, Tesoriere G, Giordano A, Vento R. 2014a. MicroRNA-29b-1 impairs in vitro cell proliferation, self-renewal and chemoresistance of human osteosarcoma 3AB-OS cancer stem cells. Int J Oncol 45:2013-2023.
15. Di Fiore R, Marcatti M, Drago-Ferrante R, D'Anneo A, Giuliano M, Carlisi D, De Blasio A, Querques F, Pastore L, Tesoriere G, Vento R. 2014b. Mutant p53 gain of function can be at the root of dedifferentiation of human osteosarcoma MG63 cells into 3AB-OS cancer stem cells. Bone 60:198-212.
16. Ferguson WS, Goorin AM. 2001. Current treatment of osteosarcoma. Cancer Invest 19:292-315.
17. Ha TY. 2011. MicroRNAs in human diseases: From cancer to cardiovascular disease. Immune Netw 11:135-154.
18. He X, Duan C, Chen J, Ou-Yang X, Zhang Z, Li C, Peng H. 2009. Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells. FEBS Lett 583:3501-3507.
19. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D, Slack FJ. 2005. RAS is regulated by the let-7 microRNA family. Cell 120:635-647.
20. Johnson CD, Esquela-Kerscher A, Stefani G, Byrom M, Kelnar K, Ovcharenko D, Wilson M, Wang X, Shelton J, Shingara J, Chin L, Brown D, Slack FJ. 2007. The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res 67:7713-7722.
21. Jones KB, Salah Z, Del Mare S, Galasso M, Gaudio E, Nuovo GJ, Lovat F, LeBlanc K, Palatini J, Randall RL, Volinia S, Stein GS, Croce CM, Lian JB, Aqeilan RI. 2012. MiRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer Res 72:1865-1877.
22. Kobayashi E, Satow R, Ono M, Masuda M, Honda K, Sakuma T, Kawai A, Morioka H, Toyama Y, Yamada T. 2014. MicroRNA expression and functional profiles of osteosarcoma. Oncol 86:94-103.
23. Kolenda T, Przybyła W, Teresiak A, Mackiewicz A, Lamperska KM. 2014. The mystery of let-7d-A small RNA with great power. Contemp Oncol (Pozn) 18:293-301.
24. Lee YS, Dutta A. 2007. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 21:1025-1030.
25. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W, Park JK, Fine HA. 2006. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9:391-403.
26. Li B, Zheng YW, Sano Y, Taniguchi H. 2011. Evidence for mesenchymal-epithelial transition associated with mouse hepatic stem cell differentiation. PLoS ONE 6:e17092.
27. Li F, Li S, Cheng T. 2014. TGF-β1 promotes osteosarcoma cell migration and invasion through the miR-143-versican pathway. Cell Physiol Biochem 34:2169-2179.
28. Liu JM, Long XH, Zhang GM, Zhou Y, Chen XY, Huang SH, Liu ZL, Zhang ZH. 2014. Let-7g reverses malignant phenotype of osteosarcoma cells by targeting Aurora-B. Int J Clin Exp Pathol 7:4596-4606.
29. Meyers PA. 2009. Muramyl tripeptide (mifamurtide) for the treatment of osteosarcoma. Expert Rev Anticancer Ther 9:1035-1049.
30. Mirabello L, Troisi RJ, Savage SA. 2009. Osteosarcoma incidence and survival rates from 1973 to 2004: Data from the surveillance, epidemiology, and end results program. Cancer 115:1531-1543.
31. Miskimins WK, Wang G, Hawkinson M, Miskimins R. 2001. Control of cyclin-dependent kinase inhibitor p27 expression by cap-independent translation. Mol Cell Biol 21:4960-4967.
32. Moyret-Lalle C, Ruiz E, Puisieux A. 2014. Epithelial-mesenchymal transition transcription factors and miRNAs: "Plastic surgeons" of breast cancer. World J Clin Oncol 5:311-322.
33. Nagadia R, Pandit P, Coman WB, Cooper-White J, Punyadeera C. 2013. MiRNAs in head and neck cancer revisited. Cell Oncol (Dordr) 36:1-7.
34. Nuovo GJ, Garofalo M, Valeri N, Roulstone V, Volinia S, Cohn DE, Phelps M, Harrington KJ, Vile R, Melcher A, Galanis E, Sehl S, Adair R, Scott K, Rose A, Toogood G, Coffey MC. 2012. Reovirus-associated reduction of microRNA-let-7d is related to the increased apoptotic death of cancer cells in clinical samples. Mod Pathol 25:1333-1344.
35. Osborne TS, Khanna C. 2012. A review of the association between osteosarcoma metastasis and protein translation. J Comp Pathol 146:132-142.
36. Patrawala L, Calhoun T, Schneider-Broussard R, Zhou J, Claypool K, Tang DG. 2005. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res 65:6207-6219.
37. Pichler M, Calin GA. 2015. MicroRNAs in cancer: From developmental genes in worms to their clinical application in patients. Br J Cancer 113:569-573.
38. Ramos MB, Soares PC, Bicalho Godoy SC, de Matos SS, Rezende Simino GP. 2014. Management of adverse effects of antineoplastic agents in children and adolescents with osteosarcoma: an integrative review. J Nurs 8:4150-4158.
39. Ricciardelli C, Mayne K, Sykes PJ, Raymond WA, McCaul K, Marshall VR, Horsfall DJ. 1998. Elevated levels of versican but not decorin predict disease progression in early-stage prostate cancer. Clin Cancer Res 4:963-971.
40. Schultz J, Lorenz P, Gross G, Ibrahim S, Kunz M. 2008. MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. Cell Res 18:549-557.
41. Sheng W, Wang G, La Pierre DP, Wen J, Deng Z, Wong CK, Lee DY, Yang BB. 2006. Versican mediates mesenchymal-epithelial transition. Mol Biol Cell 17:2009-2020.
42. Sugimura K, Miyata H, Tanaka K, Hamano R, Takahashi T, Kurokawa Y, Yamasaki M, Nakajima K, Takiguchi S, Mori M, Doki Y. 2012. Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma. Clin Cancer Res 18:5144-5153.
43. Thiery JP. 2003. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15:740-746.
44. Thuault S, Valcourt U, Petersen M, Manfioletti G, Heldin CH, Moustakas A. 2006. Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition. J Cell Biol 174:175-183.
45. Tsang WP, Kwok TT. 2008. Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3. Apoptosis 13:1215-1222.
46. Wang YC, Chen YL, Yuan RH, Pan HW, Yang WC, Hsu HC, Jeng YM. 2010. Lin-28B expression promotes transformation and invasion in human hepatocellular carcinoma. Carcinogenesis 31:1516-1522.
47. Wlodkowic D, Skommer J, Darzynkiewicz Z. 2009. Flow cytometry-based apoptosis detection. Methods Mol Biol 559:19-32.
48. Xia T, Jiang H, Li C, Zhang H. 2012. Molecular imaging in tracking tumor stem-like cells. J Biomed Biotechnol 2012:420364.
49. Zhang B, Pan X, Cobb GP, Anderson TA. 2007. MicroRNAs as oncogenes and tumor suppressors. Dev Biol 302:1-12.
50. Zhang R, He Y, Zhang X, Xing B, Sheng Y, Lu H, Wei Z. 2012. Estrogen receptor-regulated microRNAs contribute to the BCL2/BAX imbalance in endometrial adenocarcinoma and precancerous lesions. Cancer Lett 314:155-165.